Mather SJ - Search Results

1

99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives.

Decristoforo C, Mather SJ, Cholewinski W, Donnemiller E, Riccabona G, Moncayo R. Decristoforo C, et al. Among authors: mather sj. Eur J Nucl Med. 2000 Sep;27(9):1318-25. doi: 10.1007/s002590000289. Eur J Nucl Med. 2000. PMID: 11007513

2

An intrapatient comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors.

Gabriel M, Decristoforo C, Donnemiller E, Ulmer H, Watfah Rychlinski C, Mather SJ, Moncayo R. Gabriel M, et al. Among authors: mather sj. J Nucl Med. 2003 May;44(5):708-16. J Nucl Med. 2003. PMID: 12732671 Free article.

3

Technetium-99m somatostatin analogues: effect of labelling methods and peptide sequence.

Decristoforo C, Mather SJ. Decristoforo C, et al. Among authors: mather sj. Eur J Nucl Med. 1999 Aug;26(8):869-76. doi: 10.1007/s002590050461. Eur J Nucl Med. 1999. PMID: 10436200

4

99mTc-HYNIC-[Tyr3]-octreotide for imaging somatostatin-receptor-positive tumors: preclinical evaluation and comparison with 111In-octreotide.

Decristoforo C, Melendez-Alafort L, Sosabowski JK, Mather SJ. Decristoforo C, et al. Among authors: mather sj. J Nucl Med. 2000 Jun;41(6):1114-9. J Nucl Med. 2000. PMID: 10855644 Free article.

5

Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.

Decristoforo C, Cholewinski W, Donnemiller E, Riccabona G, Moncayo R, Mather SJ. Decristoforo C, et al. Among authors: mather sj. Eur J Nucl Med. 2000 Oct;27(10):1580. doi: 10.1007/s002590000354. Eur J Nucl Med. 2000. PMID: 11083550 No abstract available.

6

The influence of chelator on the pharmacokinetics of 99mTc-labelled peptides.

Decristoforo C, Mather SJ. Decristoforo C, et al. Among authors: mather sj. Q J Nucl Med. 2002 Sep;46(3):195-205. Q J Nucl Med. 2002. PMID: 12134136 Review.

7

Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys.

Kopecky M, Semecky V, Trejtnar F, Laznicek M, Laznickova A, Nachtigal P, Decristoforo C, Mather SJ, Mäcke HR. Kopecky M, et al. Among authors: mather sj. Nucl Med Biol. 2004 Feb;31(2):231-9. doi: 10.1016/j.nucmedbio.2003.06.001. Nucl Med Biol. 2004. PMID: 15013489

8

Preparation, 99mTc-labeling, and in vitro characterization of HYNIC and N3S modified RC-160 and [Tyr3]octreotide.

Decristoforo C, Mather SJ. Decristoforo C, et al. Among authors: mather sj. Bioconjug Chem. 1999 May-Jun;10(3):431-8. doi: 10.1021/bc980121c. Bioconjug Chem. 1999. PMID: 10346875

9

99m-Technetium-labelled peptide-HYNIC conjugates: effects of lipophilicity and stability on biodistribution.

Decristoforo C, Mather SJ. Decristoforo C, et al. Among authors: mather sj. Nucl Med Biol. 1999 May;26(4):389-96. doi: 10.1016/s0969-8051(98)00118-8. Nucl Med Biol. 1999. PMID: 10382842

10

Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.

von Guggenberg E, Sallegger W, Helbok A, Ocak M, King R, Mather SJ, Decristoforo C. von Guggenberg E, et al. Among authors: mather sj. J Med Chem. 2009 Aug 13;52(15):4786-93. doi: 10.1021/jm900400w. J Med Chem. 2009. PMID: 19591486

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

188 results

Search Page

Filters